Saunders is no stranger to the firm; he has been a member of its board since August 2011, and currently serves on two of its committees, compensation and compliance.
Saunders replaces Howard Solomon, who is also the company's chairman. Solomon, who joined Forest in 1964, has been CEO since 1977. After vacating the CEO post, Solomon will remain chairman through the firm's annual meeting next year. Saunders is expected to replace him at that point.
Forest Labs' incoming chief executive was most recently CEO of Bausch + Lomb, stepping down in the wake of that company's $8.7 billion acquisition by Valeant Pharmaceuticals this past May. He also held executive positions at Schering-Plough, now a part of Merck, and was a partner at PricewaterhouseCoopers.
Fool contributor Eric Volkman has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.